N-cinnamoyl derivatives of (.beta.) carbolines
US6117881A · kind A · utility
12Cited by
9References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 23, 1999 |
| Grant date | Sep 12, 2000 |
| Priority date | — |
| Expiry date | Apr 23, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Carboline derivatives of formula (I), are potent and selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase (cGMP specific PDE) and have utility in a variety of therapeutic areas where such inhibition is thought to be beneficial, including the treatment of cardiovascular disorders. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.